1068 NEW ZEALAND GAZETTE, No. 42 15 APRIL 2004

Product:
Ebixa
Active Ingredient:
Memantine hydrochloride 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited
Manufacturer:
Rottendorf Pharma GmbH, Ennigerloh, Germany
Dated this 12th day of April 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go2442

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Product:
Celebrex
Active Ingredient:
Celecoxib 100mg
Dosage Form:
Capsule
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Pharmacia, Caguas, Puerto Rico

Product:
Celebrex
Active Ingredient:
Celecoxib 200mg
Dosage Form:
Capsule
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Pharmacia, Caguas, Puerto Rico

Dated this 13th day of April 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go2441

New Zealand Public Health and Disability Act 2000

Amendment No. 3 to the Advice Notice to General Practitioners Concerning Patient Benefits and Other Subsidies Issued Pursuant to Section 88 of the New Zealand Public Health and Disability Act 2000 by All the District Health Boards With the Approval of the Minister of Health

1. Background

From 1 May 2000, the Health Funding Authority paid general practitioners according to an Advice Notice issued under section 51 of the Health and Disability Services Act 1993 ("the Notice"). The Notice set out the terms and conditions on which the Health Funding Authority would make payment to practitioners for their services. When the Health and Disability Services Act was repealed, the Notice was continued as a section 88 Advice Notice under section 112 (3) of the New Zealand Public Health and Disability Act. The Ministry of Health transferred its obligations under the Notice to District Health Boards by means of the Health Sector Transfers (Provider Arrangements) Order 2001 (S.R. 2001/135).

By this amendment, all District Health Boards, with the approval of the Minister of Health, issue these amendments to the Notice.

2. Commencement

This amendment takes effect on 19 July 2004.

3. Replacement of Schedule 3

The Notice is amended by deleting the existing Schedule 3 and replacing it with the following Schedule:

Schedule 3 – Immunisation Services

1 Childhood Immunisation Services – Preamble

1.1 Objective

The objective of immunisation services is to improve, promote and protect the health of the population, particularly children, both individually and collectively, by preventing and controlling vaccine-preventable diseases. Methods of reducing the impact and risk of vaccine-preventable diseases include:

(a) increasing the numbers and proportion of children with completed scheduled childhood immunisation on time, by the time they are two years old, and by school entry;

(b) developing and maintaining effective recall systems, which remind parents/caregivers of due dates for vaccinations and recall those who are delayed or late in receiving vaccinations;

(c) ensuring children do not "fall through the gaps" by developing effective links between services and assisting individual children to access vaccination services;